Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
Patients with type-2 diabetes have an FDA-approved medication option that will help reduce blood sugar levels in conjunction with diet and exercise. Sodium-glucose Cotransporter-2 (SGLT2) inhibitors, including canagliflozin,…
High resolution 3D printing and sophisticated fluid dynamics software will help determine sinus surgery outcomes before a patient ever reaches the operating room.
Insulin resistance is a major precursor to the development of type-2 diabetes. Obesity is the primary cause of insulin resistance in both male and female patients, but a…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
